Coverage

Latest commissioned research from ABG Sundal Collier

Nexam Chemical - Q4 in line with pre-announcement

Ferronordic - Fundamentals improving under the hood

Alligo - Winter timing means growth must wait until Q1

Read earlier research

Recent media selection from our coverage

Eolus - Company presentation with IR Harald Cavalli-Björkman

Embellence Group - Company presentation with CEO Johan Andgren

Skolon | Q3 Earnings Call with CEO Oliver Lundgren

Eastnine - Company presentation with CEO Kestutis Sasnauskas and CFO Britt-Marie Nyman

BTS Group - Company presentation with CEO Jessica Skon

PAST EVENT

Investor Days
3-4 December 2025

CLICK TO VIEW PRESENTATION

Acconeer	Inission
Ascelia Pharma	INVISIO
B3 Consulting Group	Isofol Medical
Bergman & Beving	I-Tech
BTS Group	Lumi Gruppen
Byggmästaren	Meds Apotek
C-RAD	Midsona

Catella	Nexam Chemical
Cavotec	Nilörn
CDON	NYAB
Clavister	OrganoClick
Done.AI	OssDsign

Eastnine	Ovzon
Eltel	poLight
Embellence Group	Prevas
Eolus	Proact IT Group
Ework Group	SinterCast

Ferronordic	Skolon
G5 Entertainment	Stenhus Fastigheter
Gentoo Media	StrongPoint
Green Landscaping Gr.	Studsvik
Humble Group	Svedbergs Group

Impact Coatings	Tempest Security
Infrea	Viscaria
	Xplora Technologies

Latest company news

New company at ABGSC - Isofol Medical

About ABGSC

Enabling businesses and capital to grow and perform ABG Sundal Collier is founded on an inclusive partnership culture and the ability to attract and develop top talent. The merger between Norwegian Sundal Collier and Swedish ABG in 2001 laid the foundation for today’s independent, full-service investment bank. We have a strong Nordic heritage, with operations in Norway, Sweden and Denmark and a global reach through our sales offices in Frankfurt, London, New York and Singapore. Relying on our superior transaction experience and network, we advise and guide clients when acquiring, consolidating or selling assets. With our outstanding investor access and placing power, we help corporations and entrepreneurs to finance their businesses. Through our highquality research, we enable smarter investment decisions. We are committed to excellence, and offer deep sector knowledge, extensive transaction experience and access to a large network of corporates and investors. We take great pride in always delivering first-class service, and we always seek to obtain a high degree of client satisfaction.

Past event

Investor Days
13-14 May

This seminar was recorded at
Hotel At Six in Stockholm

CLICK BELOW TO VIEW
COMPANY PRESENTATIONS

ABG Sundal Collier	Humble Group
Acast	Infrea
Alligo	INVISIO
Ascelia Pharma	Kameo
Astor Group	Lumi Gruppen
B3 Consulting Group	Medicover
Berner Industrier	Midsona
Bredband2	Nexam Chemical
Byggmästaren	Nilörn
Cedergrenska	Orexo
Cereno Scientific	OrganoClick
Clavister	OssDsign
Coor	Ovzon
CTT Systems	Proact
Eltel	Qliro
Eolus Vind	Railcare
EQL Pharma	Spiltan Invest
Freemelt	Stendörren
Freja eID	Studsvik
G5 Entertainment	Svedbergs Group
Gentoo Media	Unibap
GLG	Verve Group

Press the button and be introduced to a new random company!

Social media

Latest commissioned research from ABG Sundal Collier

Nexam Chemical - Q4 in line with pre-announcement

Ferronordic - Fundamentals improving under the hood

Alligo - Winter timing means growth must wait until Q1

Recent media selection from our coverage

New company at ABGSC - Isofol Medical

Ascelia Pharma

Ascelia Pharma - Company presentation with CEO Magnus Corfitzen

B3 Consulting Group

B3 Consulting Group - Company presentation with President & CEO Martin Stenström

Byggmästaren

Byggmästaren - Company presentation with CEO Tomas Bergström

Catella

Catella - Company presentation with CFO Michel Fischier